October 2018 – XCR Diagnostics

Posted October 30, 2018

XCR Diagnostics and Luminex Enter into License Agreement

Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR's proprietary Xtreme Chain Reaction nucleic acid [...]

By xcradmin

In News

Posted October 23, 2018

Worldwide Business with Kathy Ireland® Discusses a Better Solution for Diagnostic Testing with XCR Diagnostics

Worldwide Business with kathy ireland® is pleased to announce an exclusive interview with Mark Powelson of XCR Diagnostics to discuss their game-changing molecular diagnostic exams offering [...]

We're not around right now. But you can send us an email and we'll get back to you, asap.